NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH JUNE <strong>2003</strong> - continued <strong>2003</strong> 2002 $ $ 11 ACCOUNTS PAYABLE CURRENT Income in Advance 969,119 539,854 Sundry Creditors 21,309 41,634 GST Payable 36,572 48,952 Awards in Trust 163,088 142,454 1,190,088 772,894 12 PROVISIONS CURRENT Provision for Employee Entitlements 20,350 15,121 NON-CURRENT Provision for Employee Entitlements 1,602 5,584 Aggregate employee entitlement liability 21,952 20,705 13 REMUNERATION AND RETIREMENT BENEFITS Directors: <strong>The</strong> names <strong>of</strong> directors who have held <strong>of</strong>fice during the financial year are: 20 Helen V Dowling Helen Matthews Sue W Kirsa Catherine I Drake Paul R Muir Neil J Keen Christine M Maclean Susan M Alexander Income received or due and receivable by all directors from the company and any related parties - - Number <strong>of</strong> directors whose income from the company and any related parties was within the following bands: 0 - $9999 12 13 Retirement and Superannuation Payments: Amounts <strong>of</strong> a prescribed benefit given during year by the company or a related party to a director or prescribed superannuation fund in connection with the retirement from a prescribed <strong>of</strong>fice - - No amounts were received by directors in relation to their membership <strong>of</strong> Federal Council. No monies received by Federal Councillors were paid as a result <strong>of</strong> their Directorship <strong>of</strong> the Company. Penelope D Thornton Naomi G Burgess Michael D Wiese Danielle A Stowasser 14 SEGMENT REPORTING a) Business & Geographical Segments <strong>The</strong> company operates predominantly in one business and geographical segment, being the provision <strong>of</strong> member, pr<strong>of</strong>essional development and educational services to those in the pharmaceutical & health pr<strong>of</strong>essions within Australia. <strong>2003</strong> 2002 $ $ 15 CASH FLOW INFORMATION Reconciliation <strong>of</strong> Cash Flow from Operations with Pr<strong>of</strong>it from Ordinary Activities after Income Tax Pr<strong>of</strong>it from Ordinary Activities After Income Tax 283,142 125,761 Non Cash Flows in Pr<strong>of</strong>it from Ordinary Activities Loss on Sale <strong>of</strong> Property, Plant & Equipment 1,061 - Depreciation 15,179 11,518 Increase (Decrease) in Employee Provisions 1,247 (6,237) Changes in Assets & Liabilities: Decrease (Increase) in Current Inventories (3,131) 3,611 Decrease (Increase) in Current Receivables 38,404 (97,496) Decrease (Increase) in Prepayments (39,300) (14,707) Increase (Decrease) in Trade Creditors (20,325) 5,037 Increase (Decrease) in Awards in Trust 20,634 (18,494) Increase (Decrease) in GST Liability Clearing A/c (12,380) 7,901 Increase (Decrease) in Income in Advance 429,265 331,604 Cash Flow from Operations 713,796 348,498 <strong>The</strong> <strong>Society</strong> <strong>of</strong> <strong>Hospital</strong> Pharmacists <strong>of</strong> Australia ABN 54 004 553 806 ANNUAL REPORT <strong>2003</strong>
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH JUNE <strong>2003</strong> - continued 16 FINANCIAL INSTRUMENTS ANNUAL REPORT <strong>2003</strong> ABN 54 004 553 806 <strong>The</strong> <strong>Society</strong> <strong>of</strong> <strong>Hospital</strong> Pharmacists <strong>of</strong> Australia 21